The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 547, doi. 10.1038/sj.onc.1201513
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 1998 AND VI 16 AND IP 4
Results: 16
1
2
A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 555, doi. 10.1038/sj.onc.1201523
- By:
- Publication type:
- Article
3
U.V.C.-Induction of p53 activation and accumulation is dependent on cell cycle and pathways involving protein synthesis and phosphorylation.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 459, doi. 10.1038/sj.onc.1201528
- By:
- Publication type:
- Article
4
Identification of two distinct deleted regions on chromosome 13 in prostate cancer.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 481, doi. 10.1038/sj.onc.1201554
- By:
- Publication type:
- Article
5
Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF β-receptor juxtamembrane and kinase insert domains.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 505
- By:
- Publication type:
- Article
6
BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 489, doi. 10.1038/sj.onc.1201556
- By:
- Publication type:
- Article
7
Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 471, doi. 10.1038/sj.onc.1201557
- By:
- Publication type:
- Article
8
p21<sup>waf1</sup> can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 431, doi. 10.1038/sj.onc.1201558
- By:
- Publication type:
- Article
9
Mechanisms of p16<sup>INK4A</sup> inactivation in non small-cell lung cancers.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 497, doi. 10.1038/sj.onc.1201559
- By:
- Publication type:
- Article
10
A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTV<sup>D</sup>/myc transgenic mice.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 517, doi. 10.1038/sj.onc.1201562
- By:
- Publication type:
- Article
11
Selective binding of different p53 response elements by p53 containing complexes.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 453, doi. 10.1038/sj.onc.1201565
- By:
- Publication type:
- Article
12
ATF2 confers radiation resistance to human melanoma cells.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 523, doi. 10.1038/sj.onc.1201566
- By:
- Publication type:
- Article
13
p21<sup>WAF1</sup> induces permanent growth arrest and enhances differentiation, but does not alter apoptosis in PC12 cells.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 443, doi. 10.1038/sj.onc.1201577
- By:
- Publication type:
- Article
14
Cisplatin induces a persistent activation of JNK that is related to cell death.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 533, doi. 10.1038/sj.onc.1201578
- By:
- Publication type:
- Article
15
PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 541, doi. 10.1038/sj.onc.1201689
- By:
- Publication type:
- Article
16
Erratum.
- Published in:
- Oncogene, 1998, v. 16, n. 4, p. 561, doi. 10.1038/sj.onc.1201766
- Publication type:
- Article